IRMD Iradimed Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRMD

Price (delayed)

$44.7

Market cap

$566.09M

P/E Ratio

31.48

Dividend/share

$0.15

EPS

$1.42

Enterprise value

$522.9M

IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging ('MRI') compatible medical devices. It's the only known provider of a non-magnetic intravenous ('IV') infusion pump system ...

Highlights
IRMD's price to earnings (P/E) is 50% lower than its 5-year quarterly average of 63.0 and 11% lower than its last 4 quarters average of 35.4
Iradimed's EPS has increased by 30% YoY and by 4.4% QoQ
Iradimed's quick ratio has soared by 101% from the previous quarter but it has decreased by 5% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.iradimed.com
Peers: COO DXCM EW

Key stats

What are the main financial stats of IRMD
Market
Shares outstanding
12.66M
Market cap
$566.09M
Enterprise value
$522.9M
Valuations
Price to earnings (P/E)
31.48
Price to book (P/B)
7.44
Price to sales (P/S)
8.36
EV/EBIT
23.1
EV/EBITDA
22.31
EV/Sales
7.73
Earnings
Revenue
$67.69M
EBIT
$22.63M
EBITDA
$23.44M
Free cash flow
$10.77M
Per share
EPS
$1.42
Free cash flow per share
$0.85
Book value per share
$6.01
Revenue per share
$5.35
TBVPS
$6.74
Balance sheet
Total assets
$88.01M
Total liabilities
$11.89M
Debt
$1.94M
Equity
$76.12M
Working capital
$64.27M
Liquidity
Debt to equity
0.03
Current ratio
9.44
Quick ratio
7.64
Net debt/EBITDA
-1.84
Margins
EBITDA margin
34.6%
Gross margin
76.6%
Net margin
26.5%
Operating margin
30.7%
Efficiency
Return on assets
20.5%
Return on equity
24.6%
Return on invested capital
75.1%
Return on capital employed
28.2%
Return on sales
33.4%
Dividend
Dividend yield
0.34%
DPS
$0.15
Payout ratio
10.6%

IRMD stock price

How has the Iradimed stock price performed over time
Intraday
1.94%
1 week
6.78%
1 month
5.65%
1 year
3.59%
YTD
-5.84%
QTD
1.61%

Financial performance

How have Iradimed's revenue and profit performed over time
Revenue
$67.69M
Gross profit
$51.82M
Operating income
$20.78M
Net income
$17.92M
Gross margin
76.6%
Net margin
26.5%
Iradimed's net income has increased by 30% YoY and by 4.2% from the previous quarter
The company's operating income rose by 25% YoY and by 3.7% QoQ
The company's revenue rose by 20% YoY and by 3.2% QoQ
The gross profit is up by 19% YoY and by 3.3% QoQ

Growth

What is Iradimed's growth rate over time

Valuation

What is Iradimed stock price valuation
IRMD P/E details
P/E
31.48
P/B
7.44
P/S
8.36
EV/EBIT
23.1
EV/EBITDA
22.31
EV/Sales
7.73
IRMD's price to earnings (P/E) is 50% lower than its 5-year quarterly average of 63.0 and 11% lower than its last 4 quarters average of 35.4
Iradimed's EPS has increased by 30% YoY and by 4.4% QoQ
The price to book (P/B) is 22% higher than the 5-year quarterly average of 6.1 but 7% lower than the last 4 quarters average of 8.0
Iradimed's equity has increased by 18% YoY and by 7% QoQ
The company's revenue rose by 20% YoY and by 3.2% QoQ
The price to sales (P/S) is 8% lower than the last 4 quarters average of 9.1 and 5% lower than the 5-year quarterly average of 8.8

Efficiency

How efficient is Iradimed business performance
Iradimed's return on equity has increased by 22% YoY
The company's return on assets rose by 18% YoY
Iradimed's return on invested capital has decreased by 12% YoY and by 3.1% QoQ
Iradimed's return on sales has increased by 8% YoY

Dividends

What is IRMD's dividend
DPS
$0.15
Dividend yield
0.34%
Payout ratio
10.6%

Financial health

How did Iradimed financials performed over time
The current ratio has surged by 103% since the previous quarter and by 4.1% year-on-year
Iradimed's quick ratio has soared by 101% from the previous quarter but it has decreased by 5% YoY
The company's debt is 97% lower than its equity
The debt to equity has decreased by 25% YoY
Iradimed's equity has increased by 18% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.